Aberrant intracellular IGF-1R beta-subunit makes receptor knockout cells (IGF1R-/-) susceptible to oncogenic

Natalia Natalishvili1, Magnus Axelson, Leonard Girnita

  • 1Department of Oncology and Pathology, CCK R8:04, Karolinska Institutet, SE-171 76 Stockholm, Sweden.

Insights

Intracellular insulin-like growth factor 1 receptor (IGF-1R) beta-subunit is crucial for cell survival and oncogenic transformation. Knockdown of this aberrant beta-subunit abrogates tumor cell transformation, highlighting its functional role.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Insulin-like growth factor 1 receptor (IGF-1R) is recognized for its role in cellular transformation by oncogenes.
  • Previous studies relied on IGF-1R knockout mouse fibroblasts, limiting understanding of intracellular IGF-1R function.
  • Two R- cell variants were identified: R-s expressing IGF-1R beta-subunit and R-r lacking it.

Purpose of the Study:

  • To investigate the function of intracellular IGF-1R beta-subunit in cell survival and oncogenic transformation.
  • To determine the impact of aberrant intracellular IGF-1R on cellular response to oncogenes like H-RasV12 and polyoma middle T-antigen.

Main Methods:

  • Characterization of intracellular localization and tyrosine kinase activity of the IGF-1R beta-subunit in R-s cells.
  • Knockdown of the IGF-1R beta-subunit using siRNA in R-s cells.
  • Assessment of oncogenic transformation through colony formation in soft agar assays after oncogene introduction.

Main Results:

  • The intracellular IGF-1R beta-subunit exhibits tyrosine kinase activity and forms perinuclear aggregates.
  • Knockdown of the beta-subunit leads to cell death in R-s cells, indicating its essential role in survival.
  • R-s cells expressing the beta-subunit undergo oncogenic transformation upon introduction of H-RasV12 and/or polyoma middle T-antigen, while R-r cells do not.
  • siRNA-mediated knockdown of the aberrant beta-subunit abrogates oncogenic transformation in R-s cells.

Conclusions:

  • Intracellular IGF-1R beta-subunit possesses tyrosine kinase activity and is critical for cell survival.
  • Aberrant intracellular IGF-1R plays a significant role in oncogenic transformation, suggesting a novel mechanism in tumor development.
  • This study provides functional evidence for intracellular IGF-1R in tumor cell survival and transformation.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...